Siheyuan: Originally I just wanted to be a little transparent.

In an office building in Tsim Sha Tsui, Hong Kong Island, a business negotiation of great significance is in full swing.

The identities of the negotiating parties are extremely different.

On one side is a small pharmaceutical company that has just been established, Hong Kong United Pharmaceuticals.

On the other side, there is Yingjiang, or it can be said to be the most powerful pharmaceutical company in the world - Pfizer Pharmaceuticals.

The content of their negotiations was about the patent licensing of amoxicillin and ethambutol.

This negotiation has been going on for almost three hours, but the two sides have never been able to reach an agreement on the core issues.

"Mr. Fang, if you think the price of US$2700 million is lower than your expectations, we can add another 300 million. How about 3000 million?"

Fang Liqing, who was sitting across the negotiation table, said calmly: "Mr. Feisa, you know, this is not about money!"

"what is that?"

"Mr. Feisa, I still say that our company will not sell the patents of amoxicillin and ethambutol. Therefore, if your company still wants to cooperate with us, it is better to It’s better to give up this idea.”

"Oh, Mr. Fang, 3000 million US dollars is quite a lot. At this price, we can buy several small companies like yours!"

Lin Shengli smiled and said, "Haha, if we, United Laboratories, don't have a good product, it really won't be worth much."

“However, obviously we, United Pharmaceuticals, are not such a company, so please Mr. Feisa put away your sense of superiority!
Feisa frowned and said: "Mr. Fang, you should also know the strength of our Pfizer company. Without our nod, it would be impossible for your two drugs to pass the review and enter the North American market!"

Hearing this, Fang Liqing smiled and said: "Mr. Feisa, I have never doubted the strength of your company, but if this is the sincerity of cooperation shown by your company, then you should please come back!"

"Mr. Fang, do you really want to reject Pfizer?" Feisa asked, staring at Fang Liqing.

"It's not that I want to reject your company, but that your company has no sincerity in cooperation!"

Then, Fang Liqing sneered: "Mr. Feisa, with a mere US$3000 million, you want to buy out the patent rights of amoxicillin and ethambutol in North America. Your company is not talking about cooperation at all, but... We’re kidding!”

Hearing this, Feisa continued: "Mr. Fang, as far as I know, the performance of these two drugs of yours in the local market of Hong Kong Island does not seem to be very satisfactory. If you insist on promoting and marketing yourself, you may not be able to Made $3000 million."

After Fang Liqing glanced at Feisa, he said in a calm tone: "Mr. Feisa, where did you hear that our company's two drugs, amoxicillin and ethambutol, are not performing well in the market?"

"Do you know what our company's sales were in the Asia-Pacific region last month for these two drugs, amoxicillin and ethambutol?"

Feisayu paused and said, "I'm not sure about this!"

After hearing that Feisa couldn't explain clearly, Fang Liqing glanced at the sales manager sitting next to him and said, "Manager Tang, please introduce to Mr. Feisa our company's sales performance last month!"

Hearing this, Manager Tang opened the notepad in his hand and said calmly:
"Mr. Feisa, last month our sales team on Hong Kong Island created sales of 365 million US dollars. The sales at Bay Bay were 221 million, the Kangaroo side was 109 million, the Nanbang side was 420 million, and the Footpot Chicken side was 795 million U.S. dollars. 2100 million, plus our subsequent expansion into the Southeast Asian market, our company’s revenue last month reached [-] million!”

After listening to Manager Tang's introduction, Feisa suddenly looked confused.

The negotiations between them and United Laboratories have been going on for almost a month, and they have also investigated the situation of this company.

This federal pharmaceutical company is a new company that has only been established for more than half a year. Although the amoxicillin and ethambutol independently developed by their company are indeed two good drugs.

However, as far as they know, these two drugs have not been tested by the market. Therefore, it is still unknown whether these two drugs can be accepted by the market.

It is precisely because of this that Pfizer offered a price of US$3000 million to buy out the patent authorization of this drug in North America.

But he did not expect that the market performance of these two drugs would be so good. In Asia alone, the monthly revenue reached more than 2000 million US dollars.

Judging from the average profit level in the pharmaceutical industry, in one month, this company's profit was at least 1000 and [-] million. No wonder they refused to buy out the patent so resolutely!
From this point of view, the response of these two drugs in the market is unexpectedly good.

Then, what can be expected is that the revenue levels of these two drugs will get better and better.

By then, other domestic pharmaceutical companies in Yingjiang will probably be interested in these two drugs.

Thinking of this, Feisa, who came to negotiate, suddenly felt a bit of pressure.

After Manager Tang finished talking about the sales, Fang Li cleared his throat and said, "Mr. Feisa, we just reached an agreement this month with the European company Soxco to jointly produce and sell two drugs, amoxicillin and ethambutol. As expected, the two drugs amoxicillin and ethambutol will soon be available in Europe."

"As for North America, we can still enter the North American market even without cooperating with your company."

"After all, in addition to Pfizer, Johnson & Johnson and BMS are also very interested in our two drugs!" After listening to Fang Liqing's words, Feisa knew that they had missed the best opportunity to acquire the patents for these two drugs at a low price. .

It seems that their primary plan to achieve their goal has completely failed.

Fortunately, they have a backup plan.

Afterwards, Feisa adjusted his mood and said: "Since Mr. Fang is unwilling to sell the patent rights of amoxicillin and ethambutol, we will no longer insist, but we at Pfizer want to win the patent rights of amoxicillin and ethambutol in North America." Exclusive agency!”

Hearing this, Fang Liqing immediately offered a price: "This is negotiable, but the annual agency fee cannot be less than 8000 million US dollars, and our company also needs 30% of the sales profit!"

"8000 million is too much, we can pay 2000 million at most, and the other 30% of the sales profit has exceeded the normal drug sharing limit, up to 15%!"

"In this way, we each take a step back, 7000 million agency fees, plus 26% sales share!"

"3000 million, 18%..."

"6000 million, 22%..."

After some haggling, the two parties finally reached a consensus with an agency fee of 4800 million yuan, plus a 20% sales share!
After sending Feisa away, Fang Liqing once again met with representatives of Foot Pot Chicken Takeda Pharmaceuticals and continued to negotiate with them on the sales and promotion of amoxicillin and ethambutol.

Negotiations continued until almost seven o'clock in the evening.

After sending away the last batch of negotiating opponents and disbanding his subordinates, Fang Liqing did not bother to have dinner, but immediately returned to his residence on the top floor of the company.

After closing all the doors and windows, drawing the curtains, and once again confirming the safety of the surrounding environment, Fang Liqing took out a small transmitter from a hidden safe, and then quickly powered on for a test. The telegram, encrypted with a special password, was sent out by Fang Liqing.

After sending the report, he locked the radio station back into the safe and opened the curtains. Fang Liqing lit a cigarette for himself and stood silently by the window, looking at the bustling city of Hong Kong outside with a lot of emotion.

Almost half a year has passed since I came to Hong Kong Island.

During this period, Fang Liqing quickly took over the small pharmaceutical company United Laboratories with the help of the convenient conditions provided to him by the Ministry of Commerce.

As for United Laboratories, a small pharmaceutical company, even though it was established by people from the Ministry of Commerce, in order to maintain maximum confidentiality, except for a few comrades from the hidden front who came to establish the company in the first place, only Fang Liqing came from the country. Came here.

In the entire United Laboratories, except for him as the general manager, all staff in various departments are all locals recruited from Hong Kong Island.

There is no other way to do this.

Although our own comrades are more trustworthy and easier to use, if there are too many people from China, once it is discovered that their United Pharmaceuticals has our background, it will be extremely difficult to do business with those Western countries. .

When Fang Liqing came to Hong Kong Island, he transferred to Singapore first. Finally, as a Chinese from Singapore, he came to Hong Kong Island to acquire the pharmaceutical company United Laboratories.

After taking over the company, Fang Liqing carried out all-round promotion of amoxicillin and ethambutol according to the operation plan formulated by Lin Shengli.

In the first month, United Lab's business was only developed locally on Hong Kong Island, with revenue of less than HK$100 million.

But in the second month, their business expanded to the surrounding bays and kangaroos, and the corresponding revenue reached HK$500 million.

After that, the two drugs amoxicillin and ethambutol were recognized by many patients because of their good efficacy and stable efficacy, and they became famous.

Fang Liqing took this opportunity and immediately dispatched a marketing team to cooperate with pharmaceutical companies in countries such as Nanbang and Jianbenji, causing their company's revenue to skyrocket in the following period.

At present, the company has created nearly 2000 million U.S. dollars in profits, and with the cooperation agreements signed with Pfizer and Takeda Pharmaceuticals today, it has once again received nearly 6000 million U.S. dollars in agency fees.

As a result, in half a year, the sales of their United Pharmaceutical Company have exceeded 8000 million US dollars.

This amount has far exceeded the expectations of 800 million in the first year and 4000 million in the second year when the superiors set the expected goals for the flag mission.

It can be said that their banner project, with the amount of foreign exchange earned in just half a year, has already achieved the goal that their superiors wanted to achieve in two years.

Nowadays, the development of United Laboratories is on the right track.

Their task of earning foreign exchange has also been quite successful. Fang Liqing felt that such good news must be spread back to the country, so that all colleagues in their banner project can share this good news with him.

At this time, Fang Liqing had no idea how much commotion the good news he shared would cause in the country. (End of chapter)